Alphatec share price today

(ATEC)

Alphatec share price is $9.35 & ₹794.53 as on 21 Dec 2024, 2.30 'hrs' IST

$9.35

▲

0.5

(5.65%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Alphatec share price in Dollar and Rupees. Guide to invest in Alphatec from India. Also see the sentimental analysis on Indian investors investing in Alphatec. Get details on the Indian mutual funds that are investing in Alphatec. Get Analyst recommendations and forecasts along with all the Alphatec's financials.

Alphatec share price movements

Today's Low: $8.71
Today's High: $9.42
$9.35
6.84%
Downside
Day's Volatility :7.49%
Upside
0.69%
52 Weeks Low: $4.88
52 Weeks High: $17.34
$9.35
47.81%
Downside
52 Weeks Volatility :71.86%
Upside
46.08%

Alphatec Returns

Period	Alphatec Holdings Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	68.17%	-11.1%	0.0%
6 Months	-5.84%	-6.0%	0.0%
1 Year	-38.04%	2.7%	0.0%
3 Years	-22.73%	0.6%	-19.7%

Alphatec Key Statistics

in dollars & INR

Previous Close	$8.85
Open	$8.73
Today's High	$9.415
Today's Low	$8.71
Market Capitalization	$1.3B
Today's Volume	$2.0M
52 Week High	$17.339
52 Week Low	$4.88
Revenue TTM	$572.7M
EBITDA	$-62.6M
Earnings Per Share (EPS)	$-1.26
Profit Margin	-31.06%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-21137.14%

How to invest in Alphatec from India?

It is very easy for Indian residents to invest directly in Alphatec from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Alphatec stock in both Indian Rupees (INR) and US Dollars (USD). Search for Alphatec or ATEC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Alphatec or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Alphatec shares which would translate to 0.091 fractional shares of Alphatec as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Alphatec, in just a few clicks!

Returns in Alphatec for Indian investors in Rupees

Investment Value

₹1,00,000

Alphatec investment value today

Current value as on today

₹1,40,234

Returns

₹40,234

(+40.23%)

Returns from Alphatec Stock

₹38,038 (false-38.04%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Alphatec

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Alphatec on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 0% more investors are searching Alphatec in the last 30 days versus the previous period.

Global Institutional Holdings in Alphatec

BlackRock Inc
5.85%
Vanguard Group Inc
4.18%
Millennium Management LLC
3.13%
Bank of America Corp
3.10%
BRAIDWELL LP
2.85%
JPMorgan Chase & Co
2.83%

Analyst Recommendation on Alphatec

Buy

94%Buy

5%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Alphatec(by analysts ranked 0 to 5 stars)

Based on 17 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Alphatec

What analysts predicted

Upside of 80.48%

Current:

$9.35

Target:

$16.88

Insights on Alphatec

Price Movement
In the last 3 months, ATEC stock has moved up by 55.1%
Increasing Revenue
Revenue is up for the last 11 quarters, 70.93M → 150.71M (in $), with an average increase of 7.1% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -49.07M → -39.61M (in $), with an average increase of 7.7% per quarter
ATEC vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 59.8% return, outperforming this stock by 97.6%
ATEC vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 116.4% return, outperforming this stock by 137.0%
Price to Sales
ForATEC every $1 of sales, investors are willing to pay $2.3, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Alphatec Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$91.7M	↓ 9.87%
Net Income	$-29.0M	↑ 1163.08%
Net Profit Margin	-31.6%	↓ 29.35%

	FY19	Y/Y Change
Revenue	$113.4M	↑ 23.7%
Net Income	$-56.9M	↑ 96.38%
Net Profit Margin	-50.17%	↓ 18.57%

	FY20	Y/Y Change
Revenue	$144.9M	↑ 27.71%
Net Income	$-79.0M	↑ 38.82%
Net Profit Margin	-54.53%	↓ 4.36%

	FY21	Y/Y Change
Revenue	$243.2M	↑ 67.89%
Net Income	$-144.3M	↑ 82.71%
Net Profit Margin	-59.34%	↓ 4.81%

	FY22	Y/Y Change
Revenue	$350.9M	↑ 44.26%
Net Income	$-152.1M	↑ 5.42%
Net Profit Margin	-43.36%	↑ 15.98%

	FY23	Y/Y Change
Revenue	$482.3M	↑ 37.45%
Net Income	$-186.6M	↑ 22.67%
Net Profit Margin	-38.7%	↑ 4.66%

	Q2 FY23	Q/Q Change
Revenue	$116.9M	↑ 7.16%
Net Income	$-51.4M	↑ 18.03%
Net Profit Margin	-43.94%	↓ 4.05%

	Q3 FY23	Q/Q Change
Revenue	$118.3M	↑ 1.15%
Net Income	$-42.7M	↓ 16.98%
Net Profit Margin	-36.07%	↑ 7.87%

	Q4 FY23	Q/Q Change
Revenue	$138.0M	↑ 16.66%
Net Income	$-49.1M	↑ 15.06%
Net Profit Margin	-35.57%	↑ 0.5%

	Q1 FY24	Q/Q Change
Revenue	$138.5M	↑ 0.37%
Net Income	$-48.5M	↓ 1.19%
Net Profit Margin	-35.02%	↑ 0.55%

	Q2 FY24	Q/Q Change
Revenue	$145.6M	↑ 5.12%
Net Income	$-40.7M	↓ 16.12%
Net Profit Margin	-27.94%	↑ 7.08%

	Q3 FY24	Q/Q Change
Revenue	$150.7M	↑ 3.53%
Net Income	$-39.6M	↓ 2.62%
Net Profit Margin	-26.28%	↑ 1.66%

	FY18	Y/Y Change
Profit	$63.2M	↑ 1.45%

	FY19	Y/Y Change
Profit	$77.6M	↑ 22.7%

	FY20	Y/Y Change
Profit	$102.5M	↑ 32.1%

	FY21	Y/Y Change
Profit	$157.8M	↑ 53.91%

	FY22	Y/Y Change
Profit	$233.1M	↑ 47.73%

	FY23	Y/Y Change
Profit	$310.2M	↑ 33.1%

	Q2 FY23	Q/Q Change
Profit	$64.5M	↓ 8.35%

	Q3 FY23	Q/Q Change
Profit	$80.0M	↑ 24.03%

	Q4 FY23	Q/Q Change
Profit	$79.2M	↓ 1.09%

	Q1 FY24	Q/Q Change
Profit	$79.5M	↑ 0.37%

	Q2 FY24	Q/Q Change
Profit	$82.7M	↑ 4.09%

	Q3 FY24	Q/Q Change
Profit	$102.7M	↑ 24.19%

	FY18	Y/Y Change
Operating Cash Flow	$-25.6M	↑ 193.37%
Investing Cash Flow	$-21.7M	↑ 233.63%
Financing Cash Flow	$53.9M	↑ 202.37%

	FY19	Y/Y Change
Operating Cash Flow	$-33.1M	↑ 29.34%
Investing Cash Flow	$-13.0M	↓ 39.86%
Financing Cash Flow	$64.2M	↑ 19.11%

	FY20	Y/Y Change
Operating Cash Flow	$-46.4M	↑ 40.13%
Investing Cash Flow	$-23.9M	↑ 83.08%
Financing Cash Flow	$130.8M	↑ 103.84%

	FY21	Y/Y Change
Operating Cash Flow	$-73.4M	↑ 58.22%
Investing Cash Flow	$-157.8M	↑ 561.23%
Financing Cash Flow	$312.0M	↑ 138.45%

	FY22	Y/Y Change
Operating Cash Flow	$-75.1M	↑ 2.33%
Investing Cash Flow	$-58.3M	↓ 63.06%
Financing Cash Flow	$31.2M	↓ 89.99%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-17.9M	↓ 286.73%
Investing Cash Flow	$-75.6M	↑ 349.35%
Financing Cash Flow	$77.9M	↑ 16.1%

Alphatec Technicals Summary

Sell

Neutral

Buy

Alphatec is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Alphatec Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Alphatec Holdings Inc	-8.42%	-5.84%	-38.04%	-22.73%	32.62%
Stryker Corporation	-6.55%	7.53%	22.55%	38.08%	71.54%
Boston Scientific Corp.	-2.79%	15.96%	59.12%	110.98%	96.7%
Edwards Lifesciences Corp.	6.29%	-17.03%	-1.35%	-41.48%	-5.43%
Abbott Laboratories	-2.58%	8.48%	4.77%	-17.81%	30.77%
Medtronic Plc	-4.38%	-0.01%	-1.09%	-20.04%	-28.85%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Alphatec Holdings Inc	NA	NA	0.0	-0.44	-211.37	-0.12	NA	-0.01
Stryker Corporation	38.32	38.32	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.27	73.27	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.79	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.17	34.17	2.17	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.46	24.46	1.46	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Alphatec Holdings Inc	Buy	$1.3B	32.62%	NA	-31.06%
Stryker Corporation	Buy	$136.1B	71.54%	38.32	16.34%
Boston Scientific Corp.	Buy	$130.7B	96.7%	73.27	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-5.43%	28.88	65.86%
Abbott Laboratories	Buy	$195.0B	30.77%	34.17	13.99%
Medtronic Plc	Buy	$102.6B	-28.85%	24.46	12.06%

About Alphatec

as a medical technology company, we improve lives by providing innovative spine surgery solutions through our relentless pursuit of superior outcomes. we are dedicated to the design, development, launch and the delivery of spinal fusion products. we seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes. alphatec spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care and outcomes. please visit our website for more information: www.alphatecspine.com

Organization	Alphatec
Employees	839
CEO	Mr. Patrick S. Miles
Industry	Health Technology

Management People of Alphatec

Name	Title
Mr. Patrick S. Miles	Executive Chairman, CEO & President
Mr. J. Todd Koning	Executive VP & CFO
Mr. Scott Lish	Chief Operating Officer
Mr. David P. Sponsel	Executive Vice President of Sales
Mr. Craig E. Hunsaker	Executive VP of People and Culture
Mr. Tyson Eliot Marshall	General Counsel & Corporate Secretary
Mr. Ali Shorooghi	Senior Vice President of Marketing
Mr. Jonathan Allen	Executive Vice President of Commercial Operations
Dr. Luiz Pimenta	Chief Medical Officer
Mr. Joseph Walland	Senior Vice President of Global Imaging Solutions

Important FAQs about investing in Alphatec from India :

What is Alphatec share price today?

Alphatec share price today stands at $9.35, Open: $8.73 ; Previous Close: $8.85 ; High: $9.42 ; Low: $8.71 ; 52 Week High: $17.34 ; 52 Week Low: $4.88. The stock opens at $8.73, after a previous close of $8.85. The stock reached a daily high of $9.42 and a low of $8.71, with a 52-week high of $17.34 and a 52-week low of $4.88.

Can Indians buy Alphatec shares?

Yes, Indians can invest in the Alphatec (ATEC) from India.

With INDmoney, you can buy Alphatec at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Alphatec at zero transaction cost.

How can I buy Alphatec shares from India?

It is very easy to buy Alphatec from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Alphatec be purchased?

Yes, you can buy fractional shares of Alphatec with INDmoney app.

What are the documents required to start investing in Alphatec stocks?

To start investing in Alphatec, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.